Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Operating revenue increased 46.8% YoY to JPY4.8bn, driven by strong sales of TDM-621, especially in the US.</li><li>The company returned to profitability with an operating profit of JPY361mn, improving JPY893mn YoY, aided by forex gains.</li><li>Full-year FY04/26 forecast predicts JPY9.3bn operating revenue and JPY400mn operating profit, reversing previous year's losses.</li></ul>

Operating revenue increased 46.8% YoY to JPY4.8bn, driven by strong sales of TDM-621, especially in the US.The company returned to profitability with an operating profit of JPY361mn, improving JPY893mn YoY, aided by forex gains.Full-year FY04/26 forecast predicts JPY9.3bn operating revenue and JPY400mn operating profit, reversing previous year's losses.

3 D Matrix Ltd (7777 JP): 1H FY04/26 flash update

<ul><li>Operating revenue increased 47.7% YoY to JPY2.2bn, driven by US sales growth of JPY1.2bn (+87.7% YoY).</li><li>Recurring profit reached JPY939mn, improving JPY1.7bn YoY, aided by foreign exchange gains of JPY938mn.</li><li>R&D expenses rose 18.9% YoY to JPY168mn; SG&A expenses increased 22.0% YoY to JPY1.5bn.</li></ul>

Operating revenue increased 47.7% YoY to JPY2.2bn, driven by US sales growth of JPY1.2bn (+87.7% YoY).Recurring profit reached JPY939mn, improving JPY1.7bn YoY, aided by foreign exchange gains of JPY938mn.R&D expenses rose 18.9% YoY to JPY168mn; SG&A expenses increased 22.0% YoY to JPY1.5bn.

3 D Matrix Ltd (7777 JP): Q1 FY04/26 flash update

<ul><li>Operating revenue increased 51.1% YoY to JPY6.9bn, driven by strong sales of absorbable local hemostat TDM-621.</li><li>The company reported an operating loss of JPY1.2bn, narrowing by JPY961mn YoY, with a recurring loss of JPY2.5bn.</li><li>FY04/26 forecast anticipates JPY9.3bn operating revenue, JPY400mn operating profit, and JPY301mn net income attributable to owners.</li></ul>

Operating revenue increased 51.1% YoY to JPY6.9bn, driven by strong sales of absorbable local hemostat TDM-621.The company reported an operating loss of JPY1.2bn, narrowing by JPY961mn YoY, with a recurring loss of JPY2.5bn.FY04/26 forecast anticipates JPY9.3bn operating revenue, JPY400mn operating profit, and JPY301mn net income attributable to owners.

3 D Matrix Ltd (7777 JP): Full-year FY04/25 flash update

<ul><li>Operating revenue grew 69.5% YoY to JPY5.1bn, driven by strong sales of TDM-621 across multiple regions.</li><li>The company revised its FY04/25 forecast, expecting JPY7.0bn in revenue and a reduced operating loss of JPY769mn.</li><li>Foreign exchange fluctuations impacted recurring loss, with JPY649mn in losses due to yen appreciation against USD and EUR.</li></ul>

Operating revenue grew 69.5% YoY to JPY5.1bn, driven by strong sales of TDM-621 across multiple regions.The company revised its FY04/25 forecast, expecting JPY7.0bn in revenue and a reduced operating loss of JPY769mn.Foreign exchange fluctuations impacted recurring loss, with JPY649mn in losses due to yen appreciation against USD and EUR.

3 D Matrix Ltd (7777 JP): Q3 FY04/25 flash update

Equity Capital Markets and Advisory Business, Auctus Advisors

Auctus Advisors

Equity Capital Markets and Advisory Business

Auctus Advisors is a specialist Equity Capital Markets and Advisory business with a focus in the Energy Sector. The partners have complementary skill sets, with decades of experience across Equity Capital Markets, Investment Banking and the Energy industry. We have worked at Société Générale, Canaccord Capital, BMO Capital Markets and Schlumberger. Most recently we have worked together for many years at GMP FirstEnergy. Auctus has been set up at the beginning of a new decade in which we see significant opportunities in the Energy space. Globally, demand for energy is at record levels and continues to grow. Conversely, investment in traditional energy sources has been severely constrained. We believe this imbalance creates opportunities for both companies and investors. Auctus provides Corporate Broking, Equity Research and Investment Banking services.

Thematic (Sector/Industry)

<ul><li>AUCTUS PUBLICATIONS ________________________________________ Chariot (CHAR LN)C; Target price of £0.10 per share: Significant power transaction highlights the value of the S.</li><li>Africa electricity trading business – Etana Energy, the South African electricity trading business (49% held by Chariot) has arranged a US$55 mm guarantee finance facility through Standard Bank and secured an equity investment of up to US$20 mm from Norfund for working capital.</li><li>In exchange, Standard Bank and Norfund will hold 10% and 20% of the project’s economics, respectively, via preferred equity.</li></ul>

AUCTUS PUBLICATIONS ________________________________________ Chariot (CHAR LN)C; Target price of £0.10 per share: Significant power transaction highlights the value of the S.Africa electricity trading business – Etana Energy, the South African electricity trading business (49% held by Chariot) has arranged a US$55 mm guarantee finance facility through Standard Bank and secured an equity investment of up to US$20 mm from Norfund for working capital.In exchange, Standard Bank and Norfund will hold 10% and 20% of the project’s economics, respectively, via preferred equity.

Japan

3-D Matrix, Ltd. researches and develops medical products by applying self assembling peptide technology.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3 D Matrix Ltd (7777 JP)